In 2024, there were major advances in inflammatory bowel disease research. Treatment strategies with biologic agents for inflammatory bowel disease matured, and gut microbiota–bacteriophage–host inter...

YouTube video by Crohn's & Colitis Foundation

Study confirms that the use of anti-tumor necrosis factor drugs dramatically reduces the likelihood of perianal fistulas Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor me...